Evidence map›Paper›PMID 28120467›Full record

ArticleMedical physics2017

Classification and evaluation strategies of auto-segmentation approaches for PET: Report of AAPM task group No. 211.

Mathieu Hatt, John A Lee, Charles R Schmidtlein, Issam El Naqa, Curtis Caldwell, Elisabetta De Bernardi, Wei Lu, Shiva Das, Xavier Geets, Vincent Gregoire and 11 more

Abstract read
In one paragraph

Article in Medical physics, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 85 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
85citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

85 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Guideline
  2. EANM/SNMMI practice guideline for [European journal of nuclear medicine and molecular imaging · 2021
    Guideline
  3. Pooled it
  4. Trial
  5. Trial
  6. Article
  7. Review
  8. Predicting aggressive disease and poor outcome in endometrial cancer using preoperative [European journal of nuclear medicine and molecular imaging · 2025
    Article
  9. Article
  10. Article
  11. [Diagnostics (Basel, Switzerland) · 2024
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Lesion Dosimetry for [Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2023
    Article

25 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Mathieu HattINSERM, UMR 1101, LaTIM, University of Brest, IBSAM, Brest, France.
John A LeeUniversité catholique de Louvain (IREC/MIRO) & FNRS, Brussels, 1200, Belgium.
Charles R SchmidtleinMemorial Sloan Kettering Cancer Center, New York, NY, 10065, USA.
Issam El NaqaUniversity of Michigan, Ann Arbor, MI, 48103, USA.
Curtis CaldwellSunnybrook Health Sciences Center, Toronto, ON, M4N 3M5, Canada.
Elisabetta De BernardiUniversity of Milano-Bicocca, Monza, Italy.
Wei LuMemorial Sloan Kettering Cancer Center, New York, NY, 10065, USA.
Shiva DasUniversity of North Carolina, Chapel Hill, NC, 27599, USA.
Xavier GeetsUniversité catholique de Louvain (IREC/MIRO) & FNRS, Brussels, 1200, Belgium.
Vincent GregoireUniversité catholique de Louvain (IREC/MIRO) & FNRS, Brussels, 1200, Belgium.
Robert JerajUniversity of Wisconsin, Madison, WI, 53705, USA.
Michael P MacManusPeter MacCallum Cancer Centre, Melbourne, Australia.
Osama R MawlawiMD Anderson Cancer Center, Houston, TX, 77030, USA.
Ursula NestleUniversitätsklinikum Freiburg, Freiburg, 79106, Germany.
Andrei B PugachevUniversity of Texas Southwestern Medical Center, Dallas, TX, 75390, USA.
Heiko SchöderMemorial Sloan Kettering Cancer Center, New York, NY, 10065, USA.
Tony ShepherdTurku University Hospital, Turku, 20521, Finland.
Emiliano SpeziSchool of Engineering, Cardiff University, Cardiff, Wales, United Kingdom.
Dimitris VisvikisINSERM, UMR 1101, LaTIM, University of Brest, IBSAM, Brest, France.
Habib ZaidiGeneva University Hospital, Geneva, CH-1211, Switzerland.
Assen S KirovMemorial Sloan Kettering Cancer Center, New York, NY, 10065, USA.

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Hongbiao Carl Lekaye · 1985 to 2026
$347.4M
Quantitative PET/CT Analysis to Improve Evaluation of Tumor ResponseR01CA172638 · NCI · UNIVERSITY OF MARYLAND BALTIMORE · PI LU, WEI · 2013 to 2016
$1.3M
NCI NIH HHS P30 CA008748NCI NIH HHS R01 CA172638
6 · The paper itself

Abstract

purposeThe purpose of this educational report is to provide an overview of the present state-of-the-art PET auto-segmentation (PET-AS) algorithms and their respective validation, with an emphasis on providing the user with help in understanding the challenges and pitfalls associated with selecting and implementing a PET-AS algorithm for a particular application. APPROACH: A brief description of the different types of PET-AS algorithms is provided using a classification based on method complexity and type. The advantages and the limitations of the current PET-AS algorithms are highlighted based on current publications and existing comparison studies. A review of the available image datasets and contour evaluation metrics in terms of their applicability for establishing a standardized evaluation of PET-AS algorithms is provided. The performance requirements for the algorithms and their dependence on the application, the radiotracer used and the evaluation criteria are described and discussed. Finally, a procedure for algorithm acceptance and implementation, as well as the complementary role of manual and auto-segmentation are addressed.

findingsA large number of PET-AS algorithms have been developed within the last 20 years. Many of the proposed algorithms are based on either fixed or adaptively selected thresholds. More recently, numerous papers have proposed the use of more advanced image analysis paradigms to perform semi-automated delineation of the PET images. However, the level of algorithm validation is variable and for most published algorithms is either insufficient or inconsistent which prevents recommending a single algorithm. This is compounded by the fact that realistic image configurations with low signal-to-noise ratios (SNR) and heterogeneous tracer distributions have rarely been used. Large variations in the evaluation methods used in the literature point to the need for a standardized evaluation protocol.

conclusionsAvailable comparison studies suggest that PET-AS algorithms relying on advanced image analysis paradigms provide generally more accurate segmentation than approaches based on PET activity thresholds, particularly for realistic configurations. However, this may not be the case for simple shape lesions in situations with a narrower range of parameters, where simpler methods may also perform well. Recent algorithms which employ some type of consensus or automatic selection between several PET-AS methods have potential to overcome the limitations of the individual methods when appropriately trained. In either case, accuracy evaluation is required for each different PET scanner and scanning and image reconstruction protocol. For the simpler, less robust approaches, adaptation to scanning conditions, tumor type, and tumor location by optimization of parameters is necessary. The results from the method evaluation stage can be used to estimate the contouring uncertainty. All PET-AS contours should be critically verified by a physician. A standard test, i.e., a benchmark dedicated to evaluating both existing and future PET-AS algorithms needs to be designed, to aid clinicians in evaluating and selecting PET-AS algorithms and to establish performance limits for their acceptance for clinical use. The initial steps toward designing and building such a standard are undertaken by the task group members.

Indexed as

AlgorithmsImage Processing, Computer-AssistedPositron-Emission TomographyHumansSignal-To-Noise RatioTomography, X-Ray ComputedPET/CTPET segmentationtreatment assessmenttreatment planning

Identifiers

PMID28120467
PMCPMC5902038

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.